SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 40 filers reported holding SUNESIS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $13,000 | -35.0% | 48,707 | 0.0% | 0.00% | -50.0% |
| Q1 2020 | $20,000 | +25.0% | 48,707 | 0.0% | 0.00% | +100.0% |
| Q4 2019 | $16,000 | -54.3% | 48,707 | 0.0% | 0.00% | -66.7% |
| Q3 2019 | $35,000 | 0.0% | 48,707 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $35,000 | -40.7% | 48,707 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $59,000 | +195.0% | 48,707 | 0.0% | 0.01% | +100.0% |
| Q4 2018 | $20,000 | -80.0% | 48,707 | -3.0% | 0.00% | -70.0% |
| Q3 2018 | $100,000 | -5.7% | 50,209 | 0.0% | 0.01% | +11.1% |
| Q2 2018 | $106,000 | -22.6% | 50,209 | 0.0% | 0.01% | -43.8% |
| Q1 2018 | $137,000 | -4.9% | 50,209 | +29.0% | 0.02% | -23.8% |
| Q4 2017 | $144,000 | +128.6% | 38,930 | +19.4% | 0.02% | +110.0% |
| Q3 2017 | $63,000 | -28.4% | 32,613 | 0.0% | 0.01% | -44.4% |
| Q2 2017 | $88,000 | +8.6% | 32,613 | +64.2% | 0.02% | +20.0% |
| Q1 2017 | $81,000 | +12.5% | 19,857 | 0.0% | 0.02% | -6.2% |
| Q4 2016 | $72,000 | +2.9% | 19,857 | +24.1% | 0.02% | +6.7% |
| Q3 2016 | $70,000 | – | 15,999 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 2,125,000 | $4,505,000 | 0.51% |
| DAFNA Capital Management LLC | 373,702 | $792,000 | 0.37% |
| BVF INC/IL | 1,684,636 | $3,571,000 | 0.35% |
| OIKOS HOLDINGS LLC | 182,395 | $387,000 | 0.24% |
| Eventide Asset Management | 2,265,455 | $4,803,000 | 0.20% |
| SABBY MANAGEMENT, LLC | 512,036 | $1,086,000 | 0.17% |
| NEA Management Company, LLC | 1,298,274 | $2,752,000 | 0.13% |
| Palo Alto Investors LP | 1,162,473 | $2,464,000 | 0.10% |
| Rhenman & Partners Asset Management AB | 427,642 | $907,000 | 0.09% |
| Telemetry Investments, L.L.C. | 90,781 | $192,000 | 0.07% |